Philip D. Gregory

2017 - bluebird bio

In 2017, Philip D. Gregory earned a total compensation of $3M as Chief Scientific Officer at bluebird bio, a 47% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$212,300
Option Awards$1,761,758
Salary$405,000
Stock Awards$642,600
Other$9,000
Total$3,030,658

Gregory received $1.8M in option awards, accounting for 58% of the total pay in 2017.

Gregory also received $212.3K in non-equity incentive plan, $405K in salary, $642.6K in stock awards and $9K in other compensation.

Rankings

In 2017, Philip D. Gregory's compensation ranked 3,593rd out of 14,666 executives tracked by ExecPay. In other words, Gregory earned more than 75.5% of executives.

ClassificationRankingPercentile
All
3,593
out of 14,666
76th
Division
Manufacturing
1,240
out of 5,772
79th
Major group
Chemicals And Allied Products
348
out of 2,075
83rd
Industry group
Drugs
268
out of 1,731
85th
Industry
Biological Products, Except Diagnostic Substances
52
out of 313
83rd
Source: SEC filing on April 27, 2018.

Gregory's colleagues

We found four more compensation records of executives who worked with Philip D. Gregory at bluebird bio in 2017.

2017

Nick Leschly

bluebird bio

Chief Executive Officer

2017

Jeffrey Walsh

bluebird bio

Chief Financial and Strategy Officer

2017

David Davidson

bluebird bio

Chief Medical Officer

2017

Jason Cole

bluebird bio

Chief Legal Officer

News

In-depth

You may also like